Research Article

Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure?

Volume: 56 Number: 1 January 31, 2022
EN

Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure?

Abstract

Purpose: This study aimed to determine the expression of Bone Morphogenic Protein-4 (BMP4) in dentigerous cyst (DC), unicystic-ameloblastoma (UA), and Multicystic-ameloblastoma (MA), and assess whether this marker can be a differentiation measure. Materials and methods: This study included 30 DC, 30 UA, and 30 MA blocks if the histopathologic diagnosis of the lesion was definitive, the clinical information and medical records were complete, and the microscopic slides and the paraffin block were available. Age, gender, and location of the lesion were recorded. The samples were analyzed after the immunohistochemical staining (Envision technique). BMP-4 marker was evaluated and reported using Intensity Score (IS), Proportional Score (PS), and Total score (TS). The data were analyzed using SPSS version 21.0. Kruskal-Wallis and Mann-Whitney U tests were applied at the significance level of 0.05. Results: In this study, DCs, UA, and MA had a significant tendency to occur in males compared to females (P<0.001, P<0.001, and P<0.001 respectively), and in the mandible compared to the maxilla (P=0.02, P=0.024, and P=0.02 respectively). The epithelial IS was significantly different among three lesions (P<0.001). IS was higher in MA than UA and DC (P<0.001 and P=0.006, respectively). The IS was not significantly different among the three lesions in connective tissue and around micro-vessels (P=0.3 and P=0.26 respectively). The PS in the epithelium and connective tissue of DC, UA, and MA had no statistical difference (P=0.549 and P=0.540 respectively). The epithelial TS was statistically different among DC, UA, and MA (P<0.001). The TS was higher in UA than MA and DC (P=0.004 and P<0.001 respectively). Conclusion: The expression of BMP-4 in the epithelium was higher in ameloblastoma compared to DCs. BMP-4 is a potential measure to differentiate different types of ameloblastoma and dentigerous cyst. The differentiation of these lesions is important as the right treatment plan changes according to the diagnosis. 

Keywords

References

  1. References: 1. Huang G, Moore L, Logan RM, Gue S. Histological analysis of 41 dentigerous cysts in a paediatric population. J Oral Pathol Med. 2019;48(1):74–8.
  2. 2. Terauchi M, Akiya S, Kumagai J, Ohyama Y, Yamaguchi S. An analysis of dentigerous cysts developed around a mandibular third molar by panoramic radiographs. Dent J. 2019;7(1):1–9.
  3. 3. Tsironi K, Inglezos E, Vardas E, Mitsea A. Uprighting an impacted permanent mandibular first molar associated with a dentigerous cyst and a missing second mandibular molar — A case report. Dent J. 2019;7(3).
  4. 4. Luppi CR, Bin LR, Nemer MRM, da Silva MC, Tolentino E de S, Iwaki LCV. Odontogenic tumors: Retrospective study of 32 cases diagnosed in a stomatology center in Maringá, Paraná, Brazil. Acta Sci - Heal Sci. 2018;40(June).
  5. 5. Hendra FN, Van Cann EM, Helder MN, Ruslin M, de Visscher JG, Forouzanfar T, et al. Global incidence and profile of ameloblastoma: A systematic review and meta-analysis. Oral Dis. 2020;26(1):12–21.
  6. 6. Barrett AW, Sneddon KJ, Tighe J V., Gulati A, Newman L, Collyer J, et al. Dentigerous Cyst and Ameloblastoma of the Jaws: Correlating the Histopathological and Clinicoradiological Features Avoids a Diagnostic Pitfall. Int J Surg Pathol. 2017;25(2):141–7.
  7. 7. Hendra FN, Natsir Kalla DS, Van Cann EM, de Vet HCW, Helder MN, Forouzanfar T. Radical vs conservative treatment of intraosseous ameloblastoma: Systematic review and meta-analysis. Oral Dis. 2019;25(7):1683–96.
  8. 8. Swarup N, Nayak MT, Chowdhary Z, Mehendiratta M, Khatana S, Choi SJ, et al. Evaluation and immunolocalization of BMP4 and FGF8 in odontogenic cyst and tumors. Anal Cell Pathol. 2018;2018.

Details

Primary Language

English

Subjects

Dentistry

Journal Section

Research Article

Publication Date

January 31, 2022

Submission Date

March 27, 2021

Acceptance Date

June 13, 2021

Published in Issue

Year 2022 Volume: 56 Number: 1

APA
Sargolzaei, S., Maleki, D., & Zohary, M. (2022). Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure? European Oral Research, 56(1), 17-22. https://doi.org/10.26650/eor.2022903844
AMA
1.Sargolzaei S, Maleki D, Zohary M. Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure? EOR. 2022;56(1):17-22. doi:10.26650/eor.2022903844
Chicago
Sargolzaei, Soudabeh, Dina Maleki, and Maryam Zohary. 2022. “Expression of BMP-4 in Dentigerous Cyst and Ameloblastoma: Is It a Differentiation Measure?”. European Oral Research 56 (1): 17-22. https://doi.org/10.26650/eor.2022903844.
EndNote
Sargolzaei S, Maleki D, Zohary M (January 1, 2022) Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure? European Oral Research 56 1 17–22.
IEEE
[1]S. Sargolzaei, D. Maleki, and M. Zohary, “Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure?”, EOR, vol. 56, no. 1, pp. 17–22, Jan. 2022, doi: 10.26650/eor.2022903844.
ISNAD
Sargolzaei, Soudabeh - Maleki, Dina - Zohary, Maryam. “Expression of BMP-4 in Dentigerous Cyst and Ameloblastoma: Is It a Differentiation Measure?”. European Oral Research 56/1 (January 1, 2022): 17-22. https://doi.org/10.26650/eor.2022903844.
JAMA
1.Sargolzaei S, Maleki D, Zohary M. Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure? EOR. 2022;56:17–22.
MLA
Sargolzaei, Soudabeh, et al. “Expression of BMP-4 in Dentigerous Cyst and Ameloblastoma: Is It a Differentiation Measure?”. European Oral Research, vol. 56, no. 1, Jan. 2022, pp. 17-22, doi:10.26650/eor.2022903844.
Vancouver
1.Soudabeh Sargolzaei, Dina Maleki, Maryam Zohary. Expression of BMP-4 in dentigerous cyst and ameloblastoma: Is it a differentiation measure? EOR. 2022 Jan. 1;56(1):17-22. doi:10.26650/eor.2022903844